Copyright Reports & Markets. All rights reserved.

Global Milrinone Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Milrinone Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 0.98
    • 1.3.3 0.99
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Milrinone Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Medical
    • 1.4.3 Others
  • 1.5 Global Milrinone Injection Market Size & Forecast
    • 1.5.1 Global Milrinone Injection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Milrinone Injection Sales Quantity (2020-2031)
    • 1.5.3 Global Milrinone Injection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
    • 2.1.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Details
    • 2.1.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Major Business
    • 2.1.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Product and Services
    • 2.1.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Recent Developments/Updates
  • 2.2 PKU HealthCare Corp,.Ltd.
    • 2.2.1 PKU HealthCare Corp,.Ltd. Details
    • 2.2.2 PKU HealthCare Corp,.Ltd. Major Business
    • 2.2.3 PKU HealthCare Corp,.Ltd. Milrinone Injection Product and Services
    • 2.2.4 PKU HealthCare Corp,.Ltd. Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 PKU HealthCare Corp,.Ltd. Recent Developments/Updates
  • 2.3 LUNANLIKANG
    • 2.3.1 LUNANLIKANG Details
    • 2.3.2 LUNANLIKANG Major Business
    • 2.3.3 LUNANLIKANG Milrinone Injection Product and Services
    • 2.3.4 LUNANLIKANG Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 LUNANLIKANG Recent Developments/Updates
  • 2.4 NJCTTQ
    • 2.4.1 NJCTTQ Details
    • 2.4.2 NJCTTQ Major Business
    • 2.4.3 NJCTTQ Milrinone Injection Product and Services
    • 2.4.4 NJCTTQ Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 NJCTTQ Recent Developments/Updates
  • 2.5 Haini
    • 2.5.1 Haini Details
    • 2.5.2 Haini Major Business
    • 2.5.3 Haini Milrinone Injection Product and Services
    • 2.5.4 Haini Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Haini Recent Developments/Updates
  • 2.6 SaiLong
    • 2.6.1 SaiLong Details
    • 2.6.2 SaiLong Major Business
    • 2.6.3 SaiLong Milrinone Injection Product and Services
    • 2.6.4 SaiLong Milrinone Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 SaiLong Recent Developments/Updates

3 Competitive Environment: Milrinone Injection by Manufacturer

  • 3.1 Global Milrinone Injection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Milrinone Injection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Milrinone Injection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Milrinone Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Milrinone Injection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Milrinone Injection Manufacturer Market Share in 2024
  • 3.5 Milrinone Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Milrinone Injection Market: Region Footprint
    • 3.5.2 Milrinone Injection Market: Company Product Type Footprint
    • 3.5.3 Milrinone Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Milrinone Injection Market Size by Region
    • 4.1.1 Global Milrinone Injection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Milrinone Injection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Milrinone Injection Average Price by Region (2020-2031)
  • 4.2 North America Milrinone Injection Consumption Value (2020-2031)
  • 4.3 Europe Milrinone Injection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Milrinone Injection Consumption Value (2020-2031)
  • 4.5 South America Milrinone Injection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Milrinone Injection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Milrinone Injection Sales Quantity by Type (2020-2031)
  • 5.2 Global Milrinone Injection Consumption Value by Type (2020-2031)
  • 5.3 Global Milrinone Injection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Milrinone Injection Sales Quantity by Application (2020-2031)
  • 6.2 Global Milrinone Injection Consumption Value by Application (2020-2031)
  • 6.3 Global Milrinone Injection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Milrinone Injection Sales Quantity by Type (2020-2031)
  • 7.2 North America Milrinone Injection Sales Quantity by Application (2020-2031)
  • 7.3 North America Milrinone Injection Market Size by Country
    • 7.3.1 North America Milrinone Injection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Milrinone Injection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Milrinone Injection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Milrinone Injection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Milrinone Injection Market Size by Country
    • 8.3.1 Europe Milrinone Injection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Milrinone Injection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Milrinone Injection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Milrinone Injection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Milrinone Injection Market Size by Region
    • 9.3.1 Asia-Pacific Milrinone Injection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Milrinone Injection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Milrinone Injection Sales Quantity by Type (2020-2031)
  • 10.2 South America Milrinone Injection Sales Quantity by Application (2020-2031)
  • 10.3 South America Milrinone Injection Market Size by Country
    • 10.3.1 South America Milrinone Injection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Milrinone Injection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Milrinone Injection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Milrinone Injection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Milrinone Injection Market Size by Country
    • 11.3.1 Middle East & Africa Milrinone Injection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Milrinone Injection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Milrinone Injection Market Drivers
  • 12.2 Milrinone Injection Market Restraints
  • 12.3 Milrinone Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Milrinone Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Milrinone Injection
  • 13.3 Milrinone Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Milrinone Injection Typical Distributors
  • 14.3 Milrinone Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Milrinone Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Milrinone Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Milrinone Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Milrinone Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Milrinone Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Milrinone Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Milrinone Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Milrinone Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, PKU HealthCare Corp,.Ltd., LUNANLIKANG, NJCTTQ, Haini, SaiLong, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Milrinone Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.98
    0.99
    Others
    Market segment by Application
    Medical
    Others
    Major players covered
    Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
    PKU HealthCare Corp,.Ltd.
    LUNANLIKANG
    NJCTTQ
    Haini
    SaiLong
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Milrinone Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Milrinone Injection, with price, sales quantity, revenue, and global market share of Milrinone Injection from 2020 to 2025.
    Chapter 3, the Milrinone Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Milrinone Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Milrinone Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Milrinone Injection.
    Chapter 14 and 15, to describe Milrinone Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now